The importance of HSPs themselves in antigen presentation and cross-presentation remains
controversial. Most studies agree that as part of their molecular chaperone function, HSPs …

Patients with head and neck squamous cell carcinoma (HNSCC) are at considerable risk for
death, with 5‐year relative survival rates of approximately 60%. The profound multifaceted …

We have investigated if immunotherapy against human papilloma virus (HPV) using a viral
gene delivery platform to immunize against HPV 16 genes E6 and E7 (Ad5 [E1-, E2b-] …

Human papillomavirus (HPV)‐induced lesions are distinct in that they have targetable
foreign antigens, the expression of which is necessary to maintain the cancerous phenotype …

Human papillomavirus (HPV) is associated with the etiology of cervical carcinoma, head and
neck squamous cell carcinoma, and several other cancer types. Vaccines directed against …

Our aim was to evaluate the association of genetic polymorphisms of immunoregulatory
molecules with susceptibility to hepatocellular carcinoma (HCC). The polymorphisms in …

The development of highly sensitive HPV‐genoty** tests has opened the possibility of
treating HPV‐infected women before high‐grade lesions appear. The lack of efficient …

Esophageal squamous cell carcinoma (ESCC) is one of the common cancers with a poor
prognosis. Incidences of human papillomavirus (HPV) infection range from 0 to 67% in …

Despite progress in the management of gastrointestinal malignancies, these diseases
remain devastating maladies. Conventional treatment with chemotherapy and radiation is …

Despite impressive progress in prevention and therapy of premalignant and malignant
dysplasia the worldwide burden of cancer is relatively unchanged. Supplementation of the …